Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
Stefan EsserJason BrunettaAlexy InciarteItzchak LevyAntonella d'Arminio MonforteJohn S LambertBerend J van WelzenKatsuji TeruyaMarta BoffitoChun-Eng LiuOzlem Altuntas AydınDavid ThorpeMarion HeinzkillAndrea MarongiuTali CassidyRichard HaubrichLisa D'AmatoOlivier RobineauPublished in: HIV medicine (2023)
The findings of this study provide robust real-world evidence to support the broad use of B/F/TAF in both TN and TE people with HIV.